Letrozole 2.5mg Tablet
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Indications & Clinical Uses
- Letrozole 2.5 mg tablets contain letrozole, a non-steroidal aromatase inhibitor that lowers the amount of oestrogen the body makes.
- Letrozole is the name of the molecule rather than a brand name: the originator brand is FEMARA from Novartis, and the information here comes from the FEMARA (letrozole) tablets United States prescribing information, which also covers 2.5 mg generic tablets such as those supplied by Teva.
- The approved uses are all in postmenopausal women with hormone receptor positive breast cancer: adjuvant treatment of early breast cancer after surgery, extended adjuvant treatment following about five years of tamoxifen, and first-line and second-line treatment of advanced or metastatic disease, including cancer that has progressed after antioestrogen therapy.
- The tablets are taken by mouth at home, one 2.5 mg tablet once a day with or without food, and treatment often continues for several years.
Side Effects
- In the adjuvant breast cancer trials the commonest effects of letrozole were raised blood cholesterol, in about 52 out of 100 women, hot flushes in about 34, joint pain or arthritis in about 25, and bone fractures in about 15.
- Night sweats, flushing, tiredness, weakness, swelling, headache, dizziness, nausea, increased sweating and bone or muscle pain are also common.
- Letrozole tablets carry NO boxed warning.
- The effects that matter most over years of treatment are thinning of the bones, which can lead to osteoporosis and fractures, and rising cholesterol, so both are monitored.
- Get urgent medical help for chest pain, breathlessness, sudden weakness or trouble speaking, unusual bleeding, or yellowing of the skin or eyes.
- Because fatigue, dizziness and drowsiness can occur, take care driving or using machines until you know how the tablets affect you.
Precautions & Warnings
- Letrozole is approved for postmenopausal women only.
- It is contraindicated in pregnancy and in anyone who has had a hypersensitivity reaction to letrozole or to any ingredient of the tablet.
- It can cause fetal harm, so women who could still become pregnant must use effective contraception during treatment and for three weeks after the final dose, and should not breastfeed.
- Bone mineral density is checked before and during treatment because letrozole reduces bone density and raises fracture risk, and blood cholesterol is monitored as well.
- Women with cirrhosis or severe liver impairment take 2.5 mg every other day instead of every day; no dose change is needed for kidney impairment when creatinine clearance is 10 mL/min or above.
- Treatment usually lasts years, so keep taking the tablets even when you feel completely well.
- Store the tablets at room temperature in the original container, away from heat and moisture.
Avoid Interactions
- Tell your prescriber about every medicine, herbal product and supplement you take.
- Tamoxifen lowers letrozole blood levels by about 38%, so the two should not be taken at the same time; if you are switching from tamoxifen, follow the order and timing your oncologist sets.
- Oestrogen-containing products, including hormone replacement therapy, oestrogen creams, pessaries and oestrogen-containing contraceptives, work against the whole purpose of letrozole, which is to lower oestrogen, so discuss any of them with your oncology team before use.
- In laboratory studies letrozole inhibits the liver enzymes CYP2A6 and CYP2C19, so medicines handled by those enzymes that have a narrow safety margin are used with care.
- Cimetidine and warfarin showed no clinically important interaction.
- Alcohol is not forbidden but can add to dizziness and tiredness, and calcium and vitamin D are often advised for bone protection.
References
Frequently Asked Questions
Letrozole 2.5 mg is an aromatase inhibitor that treats hormone receptor positive breast cancer in postmenopausal women. It is used after surgery as adjuvant treatment, as extended adjuvant treatment after about five years of tamoxifen, and for advanced or metastatic breast cancer. It works by lowering the oestrogen that fuels these tumours.
Take one 2.5 mg letrozole tablet by mouth once a day, with or without food, at about the same time each day. Treatment often continues for five years or longer, so keep taking it even when you feel well. In severe liver impairment the dose is 2.5 mg every other day.
The commonest letrozole side effects are raised cholesterol, affecting about 52 in 100 women, hot flushes in about 34, joint pain in about 25 and bone fractures in about 15. Night sweats, tiredness, headache and nausea are also common. Seek urgent help for chest pain, breathlessness or sudden weakness.
Avoid taking tamoxifen with letrozole, because tamoxifen lowers letrozole levels by about 38%. Avoid oestrogen-containing products, including hormone replacement therapy and oestrogen creams, which work against the treatment. Letrozole must not be used in pregnancy. Alcohol can add to dizziness and tiredness.
If you miss a letrozole tablet, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed one and carry on as usual. Never take two tablets together to make up, and tell your oncology team if you miss several doses.
No. Letrozole is approved only for postmenopausal women, and it is contraindicated in pregnancy because it can harm an unborn baby. Women who could still become pregnant must use effective contraception during treatment and for three weeks after the last tablet, and should not breastfeed.

Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.